To compare the levels of urinary isoprostanes (UIP), a marker of lipid peroxydation expressing the degree of oxidative stress, in hypertensive and normotensive patients.
P-603 BIOCHEMICAL AND HEMODYNAMIC DETERMINANTS OF C-REACTIVE PROTEIN AS AN INFLAMMATORY MARKER OF ENDOTHELIAL DYSFUNCTION. THE IMPACT OF SYSTOLIC HYPERTENSION
Background: C-reactive protein (CRP) is a known factor of systemic inflammation and is currently conceived as a cardiovascular risk factor in the short and long term.
Aims: To know the biochemical and hemodynamic determinants of CRP. To assess its correlation with Endothelial Dysfunction (ED).
Material and Methods: Study Population: Nϭ131 patients from a cardiovascular risk population, 70 female, 61 male, aged 21-82 years (57 ϩ/-14), 52 dyslipemic (LDLc Ͼ 160mg/dl), 84 hypertensive (WHO Criteria), 50 type 2 diabetics (WHO Criteria) and 31 active smokers.
Protocol: Biochemical parameters: basal glycemia, HbAlc, total cholesterol, cLDL, cHDL, triglycerides, and lipoprotein a (Lpa).
Hemodynamic parameters: Blood Pressure Holter (Spacelabs 90210): Four periods were assessed: 1) Global 24h Period ; 2) Daytime Period (9-22h); 3) Nighttime period (22-6h); and 4) Critical Period (6-9h). ENDOTHELIAL DYSFUNCTION: endothelium-dependent vasodilatation (EDV), by Flow Mediated Vasodilatation (FMV) and endotheliumindependent vasodilatation (EIV), by sublingual nitroglycerin, were assessed by brachial artery Doppler Ultrasonography (DUS) in Nϭ58.
CRP: Behring Nephelometer II. 75% of patients with high levels of CRP had average systolic arterial blood pressure levels higher or equal to 125 mmHg versus 47 % with systolic blood pressure levels Ͻ125 (pϽ0.040). 3-A statistically significant association was found between high levels of CRP and endothelial dysfunction (22.8% ED and CRPϾ5 vs 4.34% no ED and CRPϾ5; pϽ0.05).
Conclusions: 1-Basal glycemia, HbA1c and Lpa, but not total cholesterol, cLDL nor triglycerides are biochemical factors of CRP levels elevation. 2-The degree of systolic arterial blood pressure levels could be the determinant hemodynamic factor. 3-ED associated with high CRP levels justifies by itself the high risk for acute events.
Key Words: C-Reactive Protein, Endothelial Dysfunction Obesity represents an important cardiovascular risk able to promote the onset and development of vascular inflammation. We evaluated the effects of body weight changes on circulating levels of VCAM-1, ICAM-1, E-selectin, P-Selectin, CD40L, CRP and 8-iso-PGF 2␣ , as indexes of vascular wall inflammation in obese patients. Fortyeight low risk obese patients were assigned to a 16 wk period of intense caloric restriction (800-1200 Kcal/die) and then to a 22 month period of weight mantaining diet. At baseline all the assessed parameters were significantly higher (pϽ0.0001) in obese patients than in a group of 38 nonobese subjects. Caloric restriction significantly reduced initial BMI, WHR, skinfold tickness, fasting insulin levels and all the indexes of atherogenic and thrombogenic status in obese patients. Changes in BMI showed a trend to be directly correlated with changes in adhesion molecules, CD40L, CRP and 8-iso-PGF 2␣ levels (Table) .
P-604 OBESITY AND VASCULAR WALL INFLAMMATION. EFFECTS OF WEIGH LOSS AND WEIGHT CYCLING
During the follow-up period 20 patients maintained weight loss (weight loss maintainers) while 28 patients recovered their initial body weight (weight cyclers). In weigh loss maintainers all the assessed parameters did not further change during the follow up period. By contrast, in weight cyclers adhesion molecules, CD40L, CRP and 8-iso-PGF 2␣ showed a trend to achieve the baseline value. This trend was mostly evident in the cases of E-selectin (109.3Ϯ22.1, ns vs baseline), CD40L (3.2Ϯ0.4, ns vs baseline) and CRP (3.1Ϯ0.6, ns vs baseline). Our data clearly demonstrated that weight loss downregulated endothelial activation and vascular inflammation while body weight recovery abolished these vasoprotective effects.
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